Analysis of the local and systemic inflammatory response in hospitalized infants with respiratory syncitial virus bronchiolitis

Allergologia et Immunopathologia

Volumn 43, Issue 3, 2015, Pages 264-271

  Moreno Solis G ^a,b   Torres Borrego, J ^a,b   de la Torre Aguilar, M J ^a,b   Fernandez Gutierrez F ^a,b   Llorente Cantarero, F J ^a,b   Perez Navero J L ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Maimonides Institute for Research in Biomedicine of Cordoba   (Spain)

Author keywords

Acute bronchiolitis; Chemokines; Cytokines; Hospitalization; Infants; Interleukins; Macrophage inflammatory proteins 1 and 1 RSV; Nasopharyngeal secretions; Oxygen therapy; Severity; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; CYTOKINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; FEMALE; HOSPITALIZED INFANT; HUMAN; INFANT; INFLAMMATION; MALE; NASOPHARYNGEAL ASPIRATION; OXYGEN CONSUMPTION; OXYGEN THERAPY; PROTEIN BLOOD LEVEL; RESPIRATORY SYNCYTIAL VIRUS ACUTE BRONCHIOLITIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH1 CELL; TH2 CELL; VIRAL BRONCHIOLITIS; BRONCHIOLITIS; DISEASE COURSE; HOSPITALIZATION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYPERBARIC OXYGEN THERAPY; IMMUNOLOGY; METABOLISM; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TH1 TH2 BALANCE;

BRONCHIOLITIS; CYTOKINES; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; HYPERBARIC OXYGENATION; INFANT; INFLAMMATION MEDIATORS; MALE; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TH1 CELLS; TH1-TH2 BALANCE;

EID: 84929265525     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2014.02.002     Document Type: Article

References (46)

1. Everard M.L., Swarbrick A., Wrightham M., McIntyre J., Dunkley C., James P.D., et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994, 71:428-432.
2. McNamara P.S., Flanagan B.F., Hart C.A., Smyth R.L. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005, 191:1225-1232.
3. Hussell T., Spender L.C., Georgiou A., O'Garra A., Openshaw P.J. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol 1996, 77(Pt 10):2447-2455.
4. Legg J.P., Hussain I.R., Warner J.A., Johnston S.L., Warner J.O. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003, 168:633-639.
5. Bont L., Heijnen C.J., Kavelaars A., van Aalderen W.M., Brus F., Draaisma J.T., et al. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J 1999, 14:144-149.
6. Lemanske R.F. Does respiratory syncytial viral-induced bronchiolitis result from helper T cell type 1/type 2 cytokine imbalance?. Am J Respir Crit Care Med 2003, 168:625-627.
7. Chen Z.M., Mao J.H., Du L.Z., Tang Y.M. Association of cytokine responses with disease severity in infants with respiratory syncytial virus infection. Acta Paediatr 2002, 91:914-922.
8. McNamara P.S., Flanagan B.F., Selby A.M., Hart C.A., Smyth R.L. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 2004, 23:106-112.
9. Bendelja K., Gagro A., Bace A., Lokar-Kolbas R., Krsulovic-Hresic V., Drazenovic V., et al. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000, 121:332-338.
10. Pinto R.A., Arredondo S.M., Bono M.R., Gaggero A.A., Diaz P.V. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 2006, 117:e878-e886.
11. Roman M., Calhoun W.J., Hinton K.L., Avendano L.F., Simon V., Escobar A.M., et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997, 156:190-195.
12. Brandenburg A.H., Kleinjan A., van Het Land B., Moll H.A., Timmerman H.H., de Swart R.L., et al. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000, 62:267-277.
13. Mobbs K.J., Smyth R.L., O'Hea U., Ashby D., Ritson P., Hart C.A. Cytokines in severe respiratory syncytial virus bronchiolitis. Pediatr Pulmonol 2002, 33:449-452.
14. Laham F.R., Trott A.A., Bennett B.L., Kozinetz C.A., Jewell A.M., Garofalo R.P., et al. LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics 2010, 125:e225-e233.
15. Semple M.G., Dankert H.M., Ebrahimi B., Correia J.B., Booth J.A., Stewart J.P., et al. Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS ONE 2007, 2:e1038.
16. Rosenberg H.F., Domachowske J.B. Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr Med Chem 2012, 19:1424-1431.
17. Grzeoek E., Koltan S., Debski R., Wysocki M., Gruszka M., Kubicka M., et al. Concentrations of IL-15, IL-18, IFN-gamma and activity of CD4(+). CD8(+) and NK cells at admission in children with viral bronchiolitis. Exp Ther Med 2010, 1:873-877.
18. Ferres J. Inhalation therapy in the newborn. An Esp Pediatr. 1992, 36(Suppl 49):160-163.
19. Byeon J.H., Lee J.C., Choi I.S., Yoo Y., Park S.H., Choung J.T. Comparison of cytokine responses in nasopharyngeal aspirates from children with viral lower respiratory tract infections. Acta Paediatr 2009, 98:725-730.
20. Garcia C., Soriano-Fallas A., Lozano J., Leos N., Gomez A.M., Ramilo O., et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J 2012, 31:86-89.
21. Joshi P., Kakakios A., Jayasekera J., Isaacs D. A comparison of IL-2 levels in nasopharyngeal and endotracheal aspirates of babies with respiratory syncytial viral bronchiolitis. J Allergy Clin Immunol 1998, 102:618-620.
22. Pitrez P.M., Ponzi D., Machado D.C., Bauer M.E., Jones M.H., Stein R.T. Discrepancy between cytokine production from peripheral blood mononuclear cells and nasal secretions among infants with acute bronchiolitis. Ann Allergy Asthma Immunol 2004, 92:659-662.
23. Boyce T.G., Mellen B.G., Mitchel E.F., Wright P.F., Griffin M.R. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000, 137:865-870.
24. Kristensen K., Stensballe L.G., Bjerre J., Roth D., Fisker N., Kongstad T., et al. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child 2009, 94:785-789.
25. Bradley J.P., Bacharier L.B., Bonfiglio J., Schechtman K.B., Strunk R., Storch G., et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005, 115:e7-e14.
26. Hoebee B., Rietveld E., Bont L., Oosten M., Hodemaekers H.M., Nagelkerke N.J., et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 2003, 187:2-11.
27. Puthothu B., Krueger M., Forster J., Heinze J., Weckmann M., Heinzmann A. Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J 2007, 26:1094-1098.
28. Hull J., Thomson A., Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000, 55:1023-1027.
29. Flores P., Guimaraes J., Videira Amaral J.M. Th1 and th2 cytokine expression in nasopharyngeal secretions during acute bronchiolitis in children younger than two years old. Allergol Immunopathol (Madr) 2011, 39:3-9.
30. Bermejo-Martin J.F., Garcia-Arevalo M.C., De Lejarazu R.O., Ardura J., Eiros J.M., Alonso A., et al. Predominance of Th2 cytokines. CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur Cytokine Netw 2007, 18:162-167.
31. Buck R.H., Cordle C.T., Thomas D.J., Winship T.R., Schaller J.P., Dugle J.E. Longitudinal study of intracellular T cell cytokine production in infants compared to adults. Clin Exp Immunol 2002, 128:490-497.
32. van Schaik S.M., Tristram D.A., Nagpal I.S., Hintz K.M., Welliver R.C., Welliver R.C. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999, 103:630-636.
33. van Schaik S.M., Obot N., Enhorning G., Hintz K., Gross K., Hancock G.E., et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med Virol 2000, 62:257-266.
34. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 1618-1623.
35. Laham F.R., Israele V., Casellas J.M., Garcia A.M., Lac Prugent C.M., Hoffman S.J., et al. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 2004, 189:2047-2056.
36. Guerrero-Plata A., Casola A., Garofalo R.P. Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol 2005, 79(1499):2-7.
37. Melendi G.A., Laham F.R., Monsalvo A.C., Casellas J.M., Israele V., Polack N.R., et al. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics 2007, 120:e410-e415.
38. Garofalo R.P., Patti J., Hintz K.A., Hill V., Ogra P.L., Welliver R.C. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001, 184:393-399.
39. Welliver R.C., Garofalo R.P., Ogra P.L. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J 2002, 21:457-461.
40. Bennett B.L., Garofalo R.P., Cron S.G., Hosakote Y.M., Atmar R.L., Macias C.G., et al. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 2007, 195:1532-1540.
41. Lee C.G., Yoon H.J., Zhu Z., Link H., Wang Z., Gwaltney J.M., et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth factor/vascular permeability factor. Am J Respir Cell Mol Biol 2000, 23:662-669.
42. Mella C., Suarez-Arrabal M.C., Lopez S., Stephens J., Fernandez S., Hall M.W., et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2013, 207:564-573.
43. Hassan M.A., Eldin A.M., Ahmed M.M. T-helper2/T-helper1 imbalance in respiratory syncytial virus bronchiolitis in relation to disease severity and outcome. Egypt J Immunol 2008, 15:153-160.
44. O'Donnell D.R., McGarvey M.J., Tully J.M., Balfour-Lynn I.M., Openshaw P.J. Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection. J Pediatr 1998, 133:272-274.
45. Nadal D., Wunderli W., Meurmann O., Briner J., Hirsig J. Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material. Scand J Infect Dis 1990, 22:91-93.
46. Zlateva K.T., Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr Infect Dis J 2004, 23:1065-1066.